Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.

Try Elite for Free

I

INO

Inovio Pharmaceuticals Inc

1.15

Oct 09 • 3:59 PM ET +0.06 (5.50%)

1.15

Aftermarket • 7:55 PM ET 0.00 (0.00%)

Healthcare Biotechnology USA Micro NASD

Peers: ANIX ATYR COYA CYPH LONA NRXS CGTX KLRS NRXP KALA

| Held by: VTI VXF IWC QQQS

Scroll to Statements

Index	-
Market Cap	118.91M
Enterprise Value	90.24M
Income	-67.43M
Sales	0.00M
Book/sh	0.05
Cash/sh	0.35
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	112
IPO	Dec 08, 1998

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	21.67
P/C	3.24
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	1.00
Current Ratio	1.00
Debt/Eq	1.83
LT Debt/Eq	1.17
Option/Short	Yes / Yes

EPS (ttm)	-1.18
EPS next Y	-0.43
EPS next Q	-0.20
EPS this Y	57.83%
EPS next Y	44.10%
EPS next 5Y	61.91%
EPS past 3/5Y	49.51% 32.44%
Sales past 3/5Y	-81.47% -61.18%
EPS Y/Y TTM	54.89%
Sales Y/Y TTM	-100.00%
EPS Q/Q	87.83%
Sales Q/Q	-
Earnings	Aug 12 AMC
EPS/Sales Surpr.	67.70% -

Insider Own	0.38%
Insider Trans	0.00%
Inst Own	38.84%
Inst Trans	1.39%
ROA	-114.64%
ROE	-409.87%
ROIC	-711.67%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-2.77%
SMA50	1.91%
SMA200	-13.32%
Trades

Shs Outstand	103.40M
Shs Float	103.01M
Short Float	20.21%
Short Ratio	5.45
Short Interest	20.82M
52W High	2.72 -57.72%
52W Low	0.56 104.19%
Volatility	7.39% 6.83%
ATR (14)	0.08
RSI (14)	47.25
Beta	1.64
Rel Volume	0.76
Avg Volume	3.82M
Volume	2,892,840

Perf Week	-0.86%
Perf Month	-10.16%
Perf Quarter	-0.86%
Perf Half Y	8.49%
Perf YTD	-33.91%
Perf Year	-56.60%
Perf 3Y	-73.31%
Perf 5Y	-98.54%
Perf 10Y	-98.97%
Recom	1.67
Target Price	3.17
Prev Close	1.09
Price	1.15
Change %	5.50%

Affiliate • Advertise • API and Exports • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)